Cannon Global Investment Management LLC Purchases Shares of 13,000 Establishment Labs Holdings Inc. $ESTA

Cannon Global Investment Management LLC purchased a new position in Establishment Labs Holdings Inc. (NASDAQ:ESTA) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 13,000 shares of the company’s stock, valued at approximately $738,000. Establishment Labs makes up 1.4% of Cannon Global Investment Management LLC’s holdings, making the stock its 21st biggest position.

Several other institutional investors have also recently made changes to their positions in the stock. Geode Capital Management LLC increased its holdings in Establishment Labs by 1.2% in the 2nd quarter. Geode Capital Management LLC now owns 25,917 shares of the company’s stock worth $1,105,000 after acquiring an additional 299 shares in the last quarter. Brian Low Financial Group LLC boosted its position in shares of Establishment Labs by 10.2% in the first quarter. Brian Low Financial Group LLC now owns 4,598 shares of the company’s stock worth $261,000 after purchasing an additional 424 shares during the period. Handelsbanken Fonder AB raised its position in shares of Establishment Labs by 7.3% during the 4th quarter. Handelsbanken Fonder AB now owns 8,800 shares of the company’s stock valued at $641,000 after purchasing an additional 600 shares during the period. Swiss National Bank raised its position in shares of Establishment Labs by 1.8% during the 4th quarter. Swiss National Bank now owns 34,200 shares of the company’s stock valued at $2,492,000 after purchasing an additional 600 shares during the period. Finally, Kestra Advisory Services LLC purchased a new position in shares of Establishment Labs during the 4th quarter valued at $47,000. Institutional investors own 72.91% of the company’s stock.

Insider Buying and Selling

In other Establishment Labs news, Director Quiros Juan Jose Chacon sold 105,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 6th. The stock was sold at an average price of $75.42, for a total transaction of $7,919,100.00. Following the sale, the director directly owned 927,504 shares of the company’s stock, valued at $69,952,351.68. The trade was a 10.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders sold a total of 292,500 shares of company stock valued at $20,591,021 in the last ninety days. Company insiders own 9.99% of the company’s stock.

Analysts Set New Price Targets

ESTA has been the topic of a number of recent analyst reports. Citigroup reissued a “neutral” rating on shares of Establishment Labs in a report on Wednesday, May 6th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Establishment Labs in a research note on Wednesday. Wall Street Zen cut Establishment Labs from a “buy” rating to a “hold” rating in a research report on Saturday, March 28th. BTIG Research boosted their price target on Establishment Labs from $88.00 to $90.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Finally, TD Cowen restated a “buy” rating on shares of Establishment Labs in a research note on Monday, June 8th. Seven analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $87.14.

Establishment Labs Trading Down 0.8%

ESTA stock opened at $88.38 on Friday. The firm has a fifty day moving average price of $73.62 and a 200 day moving average price of $70.35. Establishment Labs Holdings Inc. has a fifty-two week low of $33.35 and a fifty-two week high of $90.50. The company has a debt-to-equity ratio of 16.82, a quick ratio of 1.91 and a current ratio of 2.96. The firm has a market cap of $2.60 billion, a PE ratio of -59.32 and a beta of 1.11.

Establishment Labs (NASDAQ:ESTA) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.45) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.10). Establishment Labs had a negative net margin of 19.05% and a negative return on equity of 218.77%. The business had revenue of $59.88 million for the quarter, compared to analysts’ expectations of $57.40 million. During the same period in the previous year, the company earned ($0.70) EPS. Establishment Labs’s revenue for the quarter was up 44.7% compared to the same quarter last year. Sell-side analysts anticipate that Establishment Labs Holdings Inc. will post -1.07 earnings per share for the current fiscal year.

Establishment Labs Company Profile

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.